HomeCompareCSASF vs JNJ

CSASF vs JNJ: Dividend Comparison 2026

CSASF yields 2.74% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CSASF wins by $266.16M in total portfolio value
10 years
CSASF
CSASF
● Live price
2.74%
Share price
$23.61
Annual div
$0.65
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$266.19M
Annual income
$248,726,029.46
Full CSASF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — CSASF vs JNJ

📍 CSASF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCSASFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CSASF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CSASF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CSASF
Annual income on $10K today (after 15% tax)
$232.60/yr
After 10yr DRIP, annual income (after tax)
$211,417,125.04/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, CSASF beats the other by $211,413,087.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CSASF + JNJ for your $10,000?

CSASF: 50%JNJ: 50%
100% JNJ50/50100% CSASF
Portfolio after 10yr
$133.11M
Annual income
$124,365,389.67/yr
Blended yield
93.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CSASF
No analyst data
Altman Z
1.4
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CSASF buys
0
JNJ buys
0
No recent congressional trades found for CSASF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCSASFJNJ
Forward yield2.74%2.14%
Annual dividend / share$0.65$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$266.19M$30.5K
Annual income after 10y$248,726,029.46$4,749.88
Total dividends collected$264.87M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CSASF vs JNJ ($10,000, DRIP)

YearCSASF PortfolioCSASF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,247$547.30$10,594$274.49+$653.00CSASF
2$13,185$1,150.59$11,294$360.69+$1.9KCSASF
3$16,629$2,521.19$12,133$476.91+$4.5KCSASF
4$23,737$5,943.49$13,156$635.42+$10.6KCSASF
5$41,256$15,857.55$14,432$854.61+$26.8KCSASF
6$95,660$51,516.42$16,056$1,162.76+$79.6KCSASF
7$325,630$223,273.12$18,175$1,604.53+$307.5KCSASF
8$1,769,033$1,420,609.11$21,009$2,252.68+$1.75MCSASF
9$16,318,425$14,425,560.08$24,911$3,229.73+$16.29MCSASF
10$266,186,745$248,726,029.46$30,458$4,749.88+$266.16MCSASF

CSASF vs JNJ: Complete Analysis 2026

CSASFStock

Credit Saison Co., Ltd. provides leasing, finance, real estate, entertainment, and payment services in Japan and internationally. The company offers credit cards, prepaid and debit cards, smartphone-based services, and loan collection services; and payment solutions and business support services for corporate activities, as well as marketing solutions. It also engages in the credit guarantee and finance related businesses; leasing of office equipment; servicing business; real estate business; real estate leasing activities; and digital payment and asset management services, as well as develops and manages amusement centers/arcades. The company was formerly known as Seibu Credit Co., Ltd. and changed its name to Credit Saison Co., Ltd. in October 1989. Credit Saison Co., Ltd. was incorporated in 1951 and is headquartered in Tokyo, Japan.

Full CSASF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CSASF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CSASF vs SCHDCSASF vs JEPICSASF vs OCSASF vs KOCSASF vs MAINCSASF vs ABBVCSASF vs MRKCSASF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.